SH-SY5Y cells are widely used as an in vitro neuronal model, yet reliable differentiation protocols tailored for tauopathy research remain limited. Effective differentiation is essential for studying tau aggregation, propagation, and neurodegenerative mechanisms. Here, we present an optimized two-step differentiation protocol for TauP301L-expressing SH-SY5Y cells that enhances neuronal maturation and tauopathy modeling, providing a physiologically relevant system for investigating tau seeding. SH-SY5Y cells expressing TauP301L-EGFP under an inducible system were differentiated using a two-step protocol consisting of retinoic acid (RA) for 72 h, followed by brain-derived neurotrophic factor (BDNF) and RA for 72 h. Differentiated neurons were then exposed to exogenous P301L tau peptide fibrils to assess their susceptibility to tau seeding and aggregation. Differentiation resulted in increased neurite outgrowth, cholinergic marker expression (ChAT upregulation, TH downregulation), and upregulation of the mature 2N4R tau isoform. Western blot analysis showed increased T22 and pSer262 tau immunoreactivity in seeded cells, consistent with tau conformational changes and pathological phosphorylation. These findings may reflect early stages of tau misfolding but do not confirm oligomer formation. Seeding also induced neurite remodeling, varicosity formation, and reduced neurite diameter-features consistent with tau-mediated pathology involving cytoskeletal changes, organelle accumulation, or axonal transport defects. This optimized differentiation protocol provides an experimentally tractable tauopathy model for investigating tau propagation and neuronal dysfunctions in a controlled human cell context. Compared to existing SH-SY5Y differentiation methods, our system provides faster neuronal maturation, controlled TauP301L induction, and enhanced tau isoform expression, making it a valuable platform for studying early tau misfolding events and therapeutic interventions in tauopathies.

Institute of Molecular and Translational Medicine Czech Advanced Technologies and Research Institute Palacký University Olomouc Křížkovského 511 8 779 00 Olomouc Czech Republic

Institute of Molecular and Translational Medicine Faculty of Medicine and Dentistry Palacký University and University Hospital Olomouc Hněvotínská Olomouc 1333 5 779 00 Czech Republic

Zobrazit více v PubMed

Götz J, Halliday G, Nisbet RM (2019) Molecular pathogenesis of the tauopathies. Annu Rev Pathol Mech Dis 14:239–261. 10.1146/annurev-pathmechdis-012418-012936 PubMed

Langerscheidt F, Bell-Simons M, Zempel H (2024) Differentiating SH-SY5Y cells into polarized human neurons for studying endogenous and exogenous tau trafficking: four protocols to obtain neurons with noradrenergic, dopaminergic, and cholinergic properties. In: Smet-Nocca C (ed) Tau protein: methods and protocols. Springer US, New York, pp 521–532 PubMed

Agholme L, Lindström T, Kågedal K et al (2010) An in vitro model for neuroscience: differentiation of SH-SY5Y cells into cells with morphological and biochemical characteristics of mature neurons. J Alzheimer’s Dis 20:1069–1082. 10.3233/JAD-2010-091363 PubMed

de Medeiros LM, De Bastiani MA, Rico EP et al (2019) Cholinergic differentiation of human neuroblastoma SH-SY5Y cell line and its potential use as an in vitro model for Alzheimer’s disease studies. Mol Neurobiol 56:7355–7367. 10.1007/s12035-019-1605-3 PubMed

Targett IL, Crompton LA, Conway ME, Craig TJ (2024) Differentiation of SH-SY5Y neuroblastoma cells using retinoic acid and BDNF: a model for neuronal and synaptic differentiation in neurodegeneration. Vitro Cell Dev Biol Anim 60:1058–1067. 10.1007/s11626-024-00948-6 PubMed PMC

Hromadkova L, Bezdekova D, Pala J et al (2020) Brain-derived neurotrophic factor (BDNF) promotes molecular polarization and differentiation of immature neuroblastoma cells into definitive neurons. Biochim Biophys Acta BBA - Mol Cell Res 1867:118737. 10.1016/j.bbamcr.2020.118737 PubMed

Kulatunga DCM, Ranaraja U, Kim EY et al (2024) A novel APP splice variant-dependent marker system to precisely demarcate maturity in SH-SY5Y cell-derived neurons. Sci Rep 14:12113. 10.1038/s41598-024-63005-y PubMed PMC

Riegerová P, Brejcha J, Bezděková D et al (2021) Expression and localization of AβPP in SH-SY5Y cells depends on differentiation state. J Alzheimer’s Dis 82:485–491. 10.3233/JAD-201409 PubMed PMC

Li Z-F, Cui L, Jin M-M et al (2022) A Matrigel-based 3D construct of SH-SY5Y cells models the α-synuclein pathologies of Parkinson’s disease. Dis Model Mech 15:dmm049125. 10.1242/dmm.049125 PubMed PMC

Niaz A, Karunia J, Mandwie M et al (2021) Robust dopaminergic differentiation and enhanced LPS-induced neuroinflammatory response in serum-deprived human SH-SY5Y cells: implication for Parkinson’s disease. J Mol Neurosci 71:565–582. 10.1007/s12031-020-01678-6 PubMed

Alaylıoğlu M, Keskin E, Yediel BŞ, et al (2024) A novel and robust protocol for differentiation of SH-SY5Y neuroblastoma cells into neuron like cells. Noro Psikiyatr Ars 61:208–212. 10.29399/npa.28510 PubMed PMC

Wenger K, Viode A, Schlaffner CN et al (2023) Common mouse models of tauopathy reflect early but not late human disease. Mol Neurodegener 18:10. 10.1186/s13024-023-00601-y PubMed PMC

Yu K, Yao KR, Aguinaga MA et al (2024) G272V and P301L mutations induce isoform specific tau mislocalization to dendritic spines and synaptic dysfunctions in cellular models of 3R and 4R tau frontotemporal dementia. J Neurosci 44:e1215232024. 10.1523/JNEUROSCI.1215-23.2024 PubMed PMC

Wang X, Friesen E, Müller I et al (2020) Rapid generation of human neuronal cell models enabling inducible expression of proteins-of-interest for functional studies. Bio-Protoc 10:e3615. 10.21769/BioProtoc.3615 PubMed PMC

Drábek J, Das V, Dzubak P et al (2022) Laboratory techniques in cellular and molecular medicine, 1st edn. Palacký University Olomouc, Olomouc

Annadurai N, Malina L, Salmona M et al (2022) Antitumour drugs targeting tau R3 VQIVYK and Cys322 prevent seeding of endogenous tau aggregates by exogenous seeds. FEBS J 289:1929–1949. 10.1111/febs.16270 PubMed

Annadurai N, Malina L, Malohlava J et al (2022) Tau R2 and R3 are essential regions for tau aggregation, seeding and propagation. Biochimie 200:79–86. 10.1016/j.biochi.2022.05.013 PubMed

Huang ZJ, Kirkwood A, Pizzorusso T et al (1999) BDNF regulates the maturation of inhibition and the critical period of plasticity in mouse visual cortex. Cell 98:739–755. 10.1016/S0092-8674(00)81509-3 PubMed

Yamada MK, Nakanishi K, Ohba S et al (2002) Brain-derived neurotrophic factor promotes the maturation of GABAergic mechanisms in cultured hippocampal neurons. J Neurosci 22:7580. 10.1523/JNEUROSCI.22-17-07580.2002 PubMed PMC

Dmetrichuk JM, Carlone RL, Spencer GE (2006) Retinoic acid induces neurite outgrowth and growth cone turning in invertebrate neurons. Dev Biol 294:39–49. 10.1016/j.ydbio.2006.02.018 PubMed

Bell M, Zempel H (2022) SH-SY5Y-derived neurons: a human neuronal model system for investigating TAU sorting and neuronal subtype-specific TAU vulnerability. Rev Neurosci 33:1–15. 10.1515/revneuro-2020-0152 PubMed

Tang-Schomer MD, Johnson VE, Baas PW et al (2012) Partial interruption of axonal transport due to microtubule breakage accounts for the formation of periodic varicosities after traumatic axonal injury. Exp Neurol 233:364–372. 10.1016/j.expneurol.2011.10.030 PubMed PMC

Liu F, Grundke-Iqbal I, Iqbal K, Gong C-X (2005) Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation. Eur J Neurosci 22:1942–1950. 10.1111/j.1460-9568.2005.04391.x PubMed

Guo JL, Lee VM (2011) Seeding of normal tau by pathological tau conformers drives pathogenesis of Alzheimer-like tangles. J Biol Chem 286. 10.1074/jbc.M110.209296 PubMed PMC

Zhang H, Cao Y, Ma L et al (2021) Possible mechanisms of tau spread and toxicity in Alzheimer’s disease. Front Cell Dev Biol 9:707268. 10.3389/fcell.2021.707268 PubMed PMC

Van der Jeugd A, Hochgräfe K, Ahmed T et al (2012) Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human tau. Acta Neuropathol (Berl) 123:787–805. 10.1007/s00401-012-0987-3 PubMed PMC